Literature DB >> 9231919

Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.

A C de Verdière1, C Dubernet, F Némati, E Soma, M Appel, J Ferté, S Bernard, F Puisieux, P Couvreur.   

Abstract

Polyalkylcyanoacrylate (PACA) nanoparticles loaded with doxorubicin allowed multidrug resistance to be overcome in vitro. However, increased cytotoxicity is not always correlated with an increased level of intracellular drug. Although we have previously shown that PACA nanoparticles are not endocytosed by tumour cells, we report here that a direct interaction between nanoparticles and cells is a necessary requirement for overcoming resistance. In addition, the results showed that the degradation products of PACA (mainly polycyanoacrylic acid) in the presence of doxorubicin are able to increase both accumulation and cytotoxicity, thus suggesting the formation of a doxorubicin-polycyanoacrylic acid ion pair. It is therefore concluded that resistance is overcome as a result of both the adsorption of nanoparticles to the cell surface and increased doxorubicin diffusion by the accumulation of an ion pair at the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231919      PMCID: PMC2223924          DOI: 10.1038/bjc.1997.362

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein.

Authors:  P D Roepe
Journal:  Biochemistry       Date:  1992-12-22       Impact factor: 3.162

2.  Increased accumulation of drugs in multidrug-resistant cells induced by liposomes.

Authors:  L Warren; J C Jardillier; A Malarska; M G Akeli
Journal:  Cancer Res       Date:  1992-06-01       Impact factor: 12.701

Review 3.  The reversal of multidrug resistance in cancer (review).

Authors:  J A Kellen
Journal:  Anticancer Res       Date:  1993 Jul-Aug       Impact factor: 2.480

4.  Novel Cl(-)-dependent intracellular pH regulation in murine MDR 1 transfectants and potential implications.

Authors:  P D Roepe; J H Weisburg; J G Luz; M M Hoffman; L Y Wei
Journal:  Biochemistry       Date:  1994-09-13       Impact factor: 3.162

Review 5.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

6.  Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein.

Authors:  P D Roepe; L Y Wei; J Cruz; D Carlson
Journal:  Biochemistry       Date:  1993-10-19       Impact factor: 3.162

7.  Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.

Authors:  C Cuvier; L Roblot-Treupel; J M Millot; G Lizard; S Chevillard; M Manfait; P Couvreur; M F Poupon
Journal:  Biochem Pharmacol       Date:  1992-08-04       Impact factor: 5.858

8.  Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity.

Authors:  W Priebe; N T Van; T G Burke; R Perez-Soler
Journal:  Anticancer Drugs       Date:  1993-02       Impact factor: 2.248

9.  The multidrug resistance (mdr1) gene product functions as an ATP channel.

Authors:  E H Abraham; A G Prat; L Gerweck; T Seneveratne; R J Arceci; R Kramer; G Guidotti; H F Cantiello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

10.  Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells.

Authors:  A Colin de Verdière; C Dubernet; F Nemati; M F Poupon; F Puisieux; P Couvreur
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more
  25 in total

Review 1.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

2.  Activity of doxorubicin covalently bound to a novel human serum albumin microcapsule.

Authors:  M Eatock; N Church; R Harris; W Angerson; C McArdle; R French; C Twelves
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.

Authors:  Fei Ren; Ruda Chen; Ying Wang; Yabin Sun; Yaodong Jiang; Guofeng Li
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

Review 4.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

5.  Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma.

Authors:  Hasan Ebrahimi Shahmabadi; Fatemeh Movahedi; Maedeh Koohi Moftakhari Esfahani; Seyed Ebrahim Alavi; Ali Eslamifar; Gholamreza Mohammadi Anaraki; Azim Akbarzadeh
Journal:  Tumour Biol       Date:  2014-01-19

6.  Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages.

Authors:  C E Soma; C Dubernet; G Barratt; F Nemati; M Appel; S Benita; P Couvreur
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

7.  Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.

Authors:  David Powell; Sruti Chandra; Kyra Dodson; Farhana Shaheen; Kylar Wiltz; Shubha Ireland; Muniruzzaman Syed; Srikanta Dash; Thomas Wiese; Tarun Mandal; Anup Kundu
Journal:  Eur J Pharm Biopharm       Date:  2017-01-25       Impact factor: 5.571

8.  A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.

Authors:  Ho Lun Wong; Andrew M Rauth; Reina Bendayan; Janet L Manias; Manisha Ramaswamy; Zengshe Liu; Sevim Z Erhan; Xiao Yu Wu
Journal:  Pharm Res       Date:  2006-06-24       Impact factor: 4.200

Review 9.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

10.  Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.

Authors:  Xiaowei Dong; Cynthia A Mattingly; Michael T Tseng; Moo J Cho; Yang Liu; Val R Adams; Russell J Mumper
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.